Updated Jul 16, 2026
Horn Kinney has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $27K.
Kinney Horn is the Chief Business Officer at Immunome Inc., a biopharmaceutical company focused on developing antibody therapeutics. He has been involved in the company's efforts to establish a pipeline of preclinical and clinical assets in oncology and infectious diseases.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | IMNM | Immunome Inc. | S — Open-market sale | 1.1K | $25.00 | $27K |
| 2026-07-09 | IMNM | Immunome Inc. | M — Option exercise | 1.1K | $12.92 | $14K |
Kinney Horn is the Chief Business Officer at Immunome Inc., a biopharmaceutical company focused on developing antibody therapeutics. He has been involved in the company's efforts to establish a pipeline of preclinical and clinical assets in oncology and infectious diseases.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($27K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Horn Kinney profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.